Comments
Regeneron eye drug Eylea wins U.S. approval for new use
22.09.2012. | (Reuters) - Regeneron Pharmaceuticals Inc said U.S. health regulators approved the company's eye drug Eylea for a new use, potentially boosting the already soaring sales of the drug that treats a sight-robbing condition....
